Chandra Bhagat Pharma Ltd vs Curis Lifesciences Ltd Stock Comparison
Chandra Bhagat Pharma Ltd vs Curis Lifesciences Ltd Stock Comparison
Last Updated on: May 04, 2026
Key Highlights
The Latest Trading Price of Chandra Bhagat Pharma Ltd is ₹ 33 as of 27 Apr 15:30
. The P/E Ratio of Chandra Bhagat Pharma Ltd changed from 158.4 on March 2021 to 45.9 on March 2025 . This represents a CAGR of -21.94% over 5 yearsThe P/E Ratio of Curis Lifesciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Chandra Bhagat Pharma Ltd changed from ₹ 29.88 crore on March 2021 to ₹ 39.48 crore on March 2025 . This represents a CAGR of 5.73% over 5 yearsThe Market Cap of Curis Lifesciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Revenue of Chandra Bhagat Pharma Ltd is ₹ 0 crore as of Jun '24
.The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24
. The EBITDA of Chandra Bhagat Pharma Ltd is ₹ 0 crore as of Jun '24
.The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24
. The Net Profit of Chandra Bhagat Pharma Ltd is ₹ 0 crore as of Jun '24
.The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24
. The Dividend Payout of Chandra Bhagat Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Curis Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003.
Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019.
The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late.
Shree Chandravadan Bhagat.
On April 1, 2003, the Company acquired the going concern business of M/s.
Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities.
About Curis Lifesciences Ltd
Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.
Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.
FAQs for the comparison of Chandra Bhagat Pharma Ltd and Curis Lifesciences Ltd
Which company has a larger market capitalization, Chandra Bhagat Pharma Ltd or Curis Lifesciences Ltd?
Market cap of Chandra Bhagat Pharma Ltd is 24 Cr while Market cap of Curis Lifesciences Ltd is 100 Cr
What are the key factors driving the stock performance of Chandra Bhagat Pharma Ltd and Curis Lifesciences Ltd?
The stock performance of Chandra Bhagat Pharma Ltd and Curis Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Chandra Bhagat Pharma Ltd and Curis Lifesciences Ltd?
As of May 4, 2026, the Chandra Bhagat Pharma Ltd stock price is INR ₹33.0. On the other hand, Curis Lifesciences Ltd stock price is INR ₹124.9.
How do dividend payouts of Chandra Bhagat Pharma Ltd and Curis Lifesciences Ltd compare?
To compare the dividend payouts of Chandra Bhagat Pharma Ltd and Curis Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.